Jasper Therapeutics, Inc. · NASDAQ:JSPR
Kingdon Capital Management, L.L.C. reported a 5.10% stake in Jasper Therapeutics, Inc. (Schedule 13G)
Event Jul 3, 2025 · Filed Jul 11, 2025
Kingdon Capital Management, L.L.C. reported a 5.10% stake in Jasper Therapeutics, Inc., 765,000 shares, as a passive investor on Jul 3, 2025. Filed Jul 11, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 765,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 5.10% | 765,000 |
| Mark Kingdon | 5.10% | 765,000 |
Source
Related
- Jasper Therapeutics, Inc.
- Kingdon Capital Management, L.L.C.
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G/A · Kingdon Capital Management, L.L.C. · Nov 12, 2025
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026